DMAC
DiaMedica TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
DMAC vs peer average
30/100
DMAC vs. peer average (F vs. D)
Grade spread
A 1 · C 3 · D 1 · F 4
Graded peers loaded
Coverage
9 graded
82% of tracked
Peer overview
ALKS is the first available peer comparator.
Small-cap biotech with CNS/renal programs; similar binary clinical readout risk and partnership optionality.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DMAC
DiaMedica Therapeutics
ALKS
Alkermes
Grade
F
A
Momentum
9
84
Value
42
65
Sentiment
0
54
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ALKS
DMAC / ALKS
Grade Position
Below peers
DMAC vs. peer average (F vs. D)
30/100
Momentum
9
ALKSValue
42
ALKSSentiment
0
ALKSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DMAC
ALKS is the first peer returned for this comparison set.